Request for Covid-19 Impact Assessment of this Report
The United States Autoimmune Disease Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Autoimmune Disease Drug market, reaching US$ million by the year 2028. As for the Europe Autoimmune Disease Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Autoimmune Disease Drug players cover Abbott Laboratories, Pfizer, AbbVie, and Eli Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autoimmune Disease Drug Market Size 2017-2028
2.1.2 Autoimmune Disease Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Autoimmune Disease Drug Segment by Type
2.2.1 NSAIDs
2.2.2 Anti-Inflammatory
2.2.3 Interferons
2.2.4 Antihyperglycemics
2.2.5 Others
2.3 Autoimmune Disease Drug Market Size by Type
2.3.1 Autoimmune Disease Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Autoimmune Disease Drug Market Size Market Share by Type (2017-2022)
2.4 Autoimmune Disease Drug Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Type 1 Diabetes
2.4.3 Multiple Sclerosis
2.4.4 Psoriasis
2.4.5 Lupus
2.4.6 Inflammatory Bowel Disease
2.4.7 Others
2.5 Autoimmune Disease Drug Market Size by Application
2.5.1 Autoimmune Disease Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Autoimmune Disease Drug Market Size Market Share by Application (2017-2022)
3 Autoimmune Disease Drug Market Size by Player
3.1 Autoimmune Disease Drug Market Size Market Share by Players
3.1.1 Global Autoimmune Disease Drug Revenue by Players (2020-2022)
3.1.2 Global Autoimmune Disease Drug Revenue Market Share by Players (2020-2022)
3.2 Global Autoimmune Disease Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Autoimmune Disease Drug by Regions
4.1 Autoimmune Disease Drug Market Size by Regions (2017-2022)
4.2 Americas Autoimmune Disease Drug Market Size Growth (2017-2022)
4.3 APAC Autoimmune Disease Drug Market Size Growth (2017-2022)
4.4 Europe Autoimmune Disease Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Autoimmune Disease Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Autoimmune Disease Drug Market Size by Country (2017-2022)
5.2 Americas Autoimmune Disease Drug Market Size by Type (2017-2022)
5.3 Americas Autoimmune Disease Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disease Drug Market Size by Region (2017-2022)
6.2 APAC Autoimmune Disease Drug Market Size by Type (2017-2022)
6.3 APAC Autoimmune Disease Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Autoimmune Disease Drug by Country (2017-2022)
7.2 Europe Autoimmune Disease Drug Market Size by Type (2017-2022)
7.3 Europe Autoimmune Disease Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Autoimmune Disease Drug by Region (2017-2022)
8.2 Middle East & Africa Autoimmune Disease Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Autoimmune Disease Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Autoimmune Disease Drug Market Forecast
10.1 Global Autoimmune Disease Drug Forecast by Regions (2023-2028)
10.1.1 Global Autoimmune Disease Drug Forecast by Regions (2023-2028)
10.1.2 Americas Autoimmune Disease Drug Forecast
10.1.3 APAC Autoimmune Disease Drug Forecast
10.1.4 Europe Autoimmune Disease Drug Forecast
10.1.5 Middle East & Africa Autoimmune Disease Drug Forecast
10.2 Americas Autoimmune Disease Drug Forecast by Country (2023-2028)
10.2.1 United States Autoimmune Disease Drug Market Forecast
10.2.2 Canada Autoimmune Disease Drug Market Forecast
10.2.3 Mexico Autoimmune Disease Drug Market Forecast
10.2.4 Brazil Autoimmune Disease Drug Market Forecast
10.3 APAC Autoimmune Disease Drug Forecast by Region (2023-2028)
10.3.1 China Autoimmune Disease Drug Market Forecast
10.3.2 Japan Autoimmune Disease Drug Market Forecast
10.3.3 Korea Autoimmune Disease Drug Market Forecast
10.3.4 Southeast Asia Autoimmune Disease Drug Market Forecast
10.3.5 India Autoimmune Disease Drug Market Forecast
10.3.6 Australia Autoimmune Disease Drug Market Forecast
10.4 Europe Autoimmune Disease Drug Forecast by Country (2023-2028)
10.4.1 Germany Autoimmune Disease Drug Market Forecast
10.4.2 France Autoimmune Disease Drug Market Forecast
10.4.3 UK Autoimmune Disease Drug Market Forecast
10.4.4 Italy Autoimmune Disease Drug Market Forecast
10.4.5 Russia Autoimmune Disease Drug Market Forecast
10.5 Middle East & Africa Autoimmune Disease Drug Forecast by Region (2023-2028)
10.5.1 Egypt Autoimmune Disease Drug Market Forecast
10.5.2 South Africa Autoimmune Disease Drug Market Forecast
10.5.3 Israel Autoimmune Disease Drug Market Forecast
10.5.4 Turkey Autoimmune Disease Drug Market Forecast
10.5.5 GCC Countries Autoimmune Disease Drug Market Forecast
10.6 Global Autoimmune Disease Drug Forecast by Type (2023-2028)
10.7 Global Autoimmune Disease Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Autoimmune Disease Drug Product Offered
11.1.3 Abbott Laboratories Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Autoimmune Disease Drug Product Offered
11.2.3 Pfizer Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Autoimmune Disease Drug Product Offered
11.3.3 AbbVie Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Autoimmune Disease Drug Product Offered
11.4.3 Eli Lilly Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Autoimmune Disease Drug Product Offered
11.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Company Information
11.6.2 AstraZeneca plc Autoimmune Disease Drug Product Offered
11.6.3 AstraZeneca plc Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca plc Main Business Overview
11.6.5 AstraZeneca plc Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline Autoimmune Disease Drug Product Offered
11.7.3 GlaxoSmithKline Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Autoimmune Disease Drug Product Offered
11.8.3 Roche Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Biogen
11.9.1 Biogen Company Information
11.9.2 Biogen Autoimmune Disease Drug Product Offered
11.9.3 Biogen Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Biogen Main Business Overview
11.9.5 Biogen Latest Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Autoimmune Disease Drug Product Offered
11.10.3 Amgen Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Amgen Main Business Overview
11.10.5 Amgen Latest Developments
12 Research Findings and Conclusion
Table 1. Autoimmune Disease Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of NSAIDs
Table 3. Major Players of Anti-Inflammatory
Table 4. Major Players of Interferons
Table 5. Major Players of Antihyperglycemics
Table 6. Major Players of Others
Table 7. Autoimmune Disease Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Autoimmune Disease Drug Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Autoimmune Disease Drug Market Size Market Share by Type (2017-2022)
Table 10. Autoimmune Disease Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Autoimmune Disease Drug Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Autoimmune Disease Drug Market Size Market Share by Application (2017-2022)
Table 13. Global Autoimmune Disease Drug Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Autoimmune Disease Drug Revenue Market Share by Player (2020-2022)
Table 15. Autoimmune Disease Drug Key Players Head office and Products Offered
Table 16. Autoimmune Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Autoimmune Disease Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Autoimmune Disease Drug Market Size Market Share by Regions (2017-2022)
Table 21. Americas Autoimmune Disease Drug Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Autoimmune Disease Drug Market Size Market Share by Country (2017-2022)
Table 23. Americas Autoimmune Disease Drug Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Autoimmune Disease Drug Market Size Market Share by Type (2017-2022)
Table 25. Americas Autoimmune Disease Drug Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Autoimmune Disease Drug Market Size Market Share by Application (2017-2022)
Table 27. APAC Autoimmune Disease Drug Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Autoimmune Disease Drug Market Size Market Share by Region (2017-2022)
Table 29. APAC Autoimmune Disease Drug Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Autoimmune Disease Drug Market Size Market Share by Type (2017-2022)
Table 31. APAC Autoimmune Disease Drug Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Autoimmune Disease Drug Market Size Market Share by Application (2017-2022)
Table 33. Europe Autoimmune Disease Drug Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Autoimmune Disease Drug Market Size Market Share by Country (2017-2022)
Table 35. Europe Autoimmune Disease Drug Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Autoimmune Disease Drug Market Size Market Share by Type (2017-2022)
Table 37. Europe Autoimmune Disease Drug Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Autoimmune Disease Drug Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Autoimmune Disease Drug Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Autoimmune Disease Drug Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Autoimmune Disease Drug Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Autoimmune Disease Drug Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Autoimmune Disease Drug Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Autoimmune Disease Drug Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Autoimmune Disease Drug
Table 46. Key Market Challenges & Risks of Autoimmune Disease Drug
Table 47. Key Industry Trends of Autoimmune Disease Drug
Table 48. Global Autoimmune Disease Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Autoimmune Disease Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Autoimmune Disease Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Autoimmune Disease Drug Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Autoimmune Disease Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Autoimmune Disease Drug Market Size Market Share Forecast by Application (2023-2028)
Table 54. Abbott Laboratories Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 55. Abbott Laboratories Autoimmune Disease Drug Product Offered
Table 56. Abbott Laboratories Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Abbott Laboratories Main Business
Table 58. Abbott Laboratories Latest Developments
Table 59. Pfizer Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 60. Pfizer Autoimmune Disease Drug Product Offered
Table 61. Pfizer Main Business
Table 62. Pfizer Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Pfizer Latest Developments
Table 64. AbbVie Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 65. AbbVie Autoimmune Disease Drug Product Offered
Table 66. AbbVie Main Business
Table 67. AbbVie Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. AbbVie Latest Developments
Table 69. Eli Lilly Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 70. Eli Lilly Autoimmune Disease Drug Product Offered
Table 71. Eli Lilly Main Business
Table 72. Eli Lilly Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Eli Lilly Latest Developments
Table 74. Bristol-Myers Squibb Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 75. Bristol-Myers Squibb Autoimmune Disease Drug Product Offered
Table 76. Bristol-Myers Squibb Main Business
Table 77. Bristol-Myers Squibb Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. AstraZeneca plc Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 80. AstraZeneca plc Autoimmune Disease Drug Product Offered
Table 81. AstraZeneca plc Main Business
Table 82. AstraZeneca plc Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. AstraZeneca plc Latest Developments
Table 84. GlaxoSmithKline Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 85. GlaxoSmithKline Autoimmune Disease Drug Product Offered
Table 86. GlaxoSmithKline Main Business
Table 87. GlaxoSmithKline Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. GlaxoSmithKline Latest Developments
Table 89. Roche Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 90. Roche Autoimmune Disease Drug Product Offered
Table 91. Roche Main Business
Table 92. Roche Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Roche Latest Developments
Table 94. Biogen Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 95. Biogen Autoimmune Disease Drug Product Offered
Table 96. Biogen Main Business
Table 97. Biogen Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Biogen Latest Developments
Table 99. Amgen Details, Company Type, Autoimmune Disease Drug Area Served and Its Competitors
Table 100. Amgen Autoimmune Disease Drug Product Offered
Table 101. Amgen Main Business
Table 102. Amgen Autoimmune Disease Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Amgen Latest Developments
List of Figures
Figure 1. Autoimmune Disease Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Autoimmune Disease Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Autoimmune Disease Drug Market Size Market Share by Type in 2021
Figure 7. Autoimmune Disease Drug in Rheumatoid Arthritis
Figure 8. Global Autoimmune Disease Drug Market: Rheumatoid Arthritis (2017-2022) & ($ Millions)
Figure 9. Autoimmune Disease Drug in Type 1 Diabetes
Figure 10. Global Autoimmune Disease Drug Market: Type 1 Diabetes (2017-2022) & ($ Millions)
Figure 11. Autoimmune Disease Drug in Multiple Sclerosis
Figure 12. Global Autoimmune Disease Drug Market: Multiple Sclerosis (2017-2022) & ($ Millions)
Figure 13. Autoimmune Disease Drug in Psoriasis
Figure 14. Global Autoimmune Disease Drug Market: Psoriasis (2017-2022) & ($ Millions)
Figure 15. Autoimmune Disease Drug in Lupus
Figure 16. Global Autoimmune Disease Drug Market: Lupus (2017-2022) & ($ Millions)
Figure 17. Autoimmune Disease Drug in Inflammatory Bowel Disease
Figure 18. Global Autoimmune Disease Drug Market: Inflammatory Bowel Disease (2017-2022) & ($ Millions)
Figure 19. Autoimmune Disease Drug in Others
Figure 20. Global Autoimmune Disease Drug Market: Others (2017-2022) & ($ Millions)
Figure 21. Global Autoimmune Disease Drug Market Size Market Share by Application in 2021
Figure 22. Global Autoimmune Disease Drug Revenue Market Share by Player in 2021
Figure 23. Global Autoimmune Disease Drug Market Size Market Share by Regions (2017-2022)
Figure 24. Americas Autoimmune Disease Drug Market Size 2017-2022 ($ Millions)
Figure 25. APAC Autoimmune Disease Drug Market Size 2017-2022 ($ Millions)
Figure 26. Europe Autoimmune Disease Drug Market Size 2017-2022 ($ Millions)
Figure 27. Middle East & Africa Autoimmune Disease Drug Market Size 2017-2022 ($ Millions)
Figure 28. Americas Autoimmune Disease Drug Value Market Share by Country in 2021
Figure 29. Americas Autoimmune Disease Drug Consumption Market Share by Type in 2021
Figure 30. Americas Autoimmune Disease Drug Market Size Market Share by Application in 2021
Figure 31. United States Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Canada Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Mexico Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Brazil Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. APAC Autoimmune Disease Drug Market Size Market Share by Region in 2021
Figure 36. APAC Autoimmune Disease Drug Market Size Market Share by Application in 2021
Figure 37. China Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. Japan Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Korea Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Southeast Asia Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. India Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Australia Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Europe Autoimmune Disease Drug Market Size Market Share by Country in 2021
Figure 44. Europe Autoimmune Disease Drug Market Size Market Share by Type in 2021
Figure 45. Europe Autoimmune Disease Drug Market Size Market Share by Application in 2021
Figure 46. Germany Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. France Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. UK Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Italy Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. Russia Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Middle East & Africa Autoimmune Disease Drug Market Size Market Share by Region in 2021
Figure 52. Middle East & Africa Autoimmune Disease Drug Market Size Market Share by Type in 2021
Figure 53. Middle East & Africa Autoimmune Disease Drug Market Size Market Share by Application in 2021
Figure 54. Egypt Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 55. South Africa Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 56. Israel Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 57. Turkey Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 58. GCC Country Autoimmune Disease Drug Market Size Growth 2017-2022 ($ Millions)
Figure 59. Americas Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 60. APAC Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 61. Europe Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 62. Middle East & Africa Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 63. United States Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 64. Canada Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 65. Mexico Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 66. Brazil Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 67. China Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 68. Japan Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 69. Korea Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 70. Southeast Asia Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 71. India Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 72. Australia Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 73. Germany Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 74. France Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 75. UK Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 76. Italy Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 77. Russia Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 78. Spain Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 79. Egypt Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 80. South Africa Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 81. Israel Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 82. Turkey Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
Figure 83. GCC Countries Autoimmune Disease Drug Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...